Bokarev I N, Kanevskaia M Z
Kafedra vnutrennikh bolezneĭ No. 3 Pervogo lechebnogo fakulteta MMA im. I.M. Sechenova na baze gorodskoĭ klinicheskoĭ bol'nitsy No. 20, Moskva.
Klin Med (Mosk). 1997;75(7):22-5.
183 patients with rheumatoid arthritis (RA) received basic drugs for 3 to 15 years. The patients were followed up for 13.5 years, on the average, with intervals 6-48 months. Clinical, laboratory, instrumental and morphological methods of investigation were used. The findings are reviewed on the mortality and causes of death, lethal tumors, overall complications and those observed in 55 patients on glucocorticoids.
183例类风湿关节炎（RA）患者接受基础药物治疗3至15年。患者平均随访13.5年，随访间隔为6至48个月。采用了临床、实验室、仪器检查和形态学检查方法。本文回顾了关于死亡率和死亡原因、致死性肿瘤、总体并发症以及55例使用糖皮质激素患者所观察到的并发症的研究结果。
